CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT by and among Merck Sharp & Dohme B.V. and OncoSec Medical Incorporated Dated: May 7, 2018Clinical Trial Collaboration and Supply Agreement • June 13th, 2018 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • New York
This CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT (this “Agreement”), is entered into as of May 7, 2018 (the “Effective Date”), by and among Merck Sharp & Dohme B.V., having a place of business at Waarderweg 39, 2031 BN Haarlem, Netherlands (“Merck”), and OncoSec Medical Incorporated, having a place of business at 5820 Nancy Ridge Drive, San Diego, California 92121 USA (“Company”). Merck and Company are each referred to herein individually as “Party” and collectively as “Parties”.
CONFIDENTIAL SEPARATION AGREEMENTConfidential Separation Agreement • June 13th, 2018 • ONCOSEC MEDICAL Inc • Pharmaceutical preparations • California
THIS AGREEMENT (the “Agreement”) is entered into as of May 2, 2018, as defined in Paragraph 8 hereof, by and between OncoSec Medical Incorporated (the “Company”) and Punit S. Dhillon (“Executive”). Together, the Company and Executive may be referred to hereinafter as the “Parties.”
SUBLEASEONCOSEC MEDICAL Inc • June 13th, 2018 • Pharmaceutical preparations • California
